In the United States, SLE remains associated with substantial mortality, particularly among Non-Hispanic Black women.
A new study found peer-mentoring interventions on self-reported disease activity, symptom severity, and flare frequency among adult African American women with systemic lupus erythematosus (SLE) may ...
Several social determinants of health were associated with increased risks for organ damage and mortality among patients newly diagnosed with SLE.
Clinical Trials Arena on MSN

SLE: Four trials to watch in 2026

As The European Lupus Society’s 15th annual soiree approaches, the Clinical Trials Arena team takes a look at four promising therapies in the SLE pipeline.
The presence of autoantibodies in apparently healthy individuals has been increasingly recognized. Although some of these individuals are in preclinical stages of a disease such as systemic lupus ...
Data suggest incidence and prevalence of systemic lupus erythematosus (SLE) vary widely among regions, although the authors noted some regions have been studied more extensively than others. A new ...
Worldwide incidence and prevalence estimates of systemic lupus erythematosus (SLE) vary substantially and are influenced by ethnic and geographic differences, study design and environmental exposures ...
Skin manifestations are common in patients with SLE. A recent study reported increased site-specific recurrence of cutaneous lupus erythematosus (CLE).1 While this study included a proportion of ...
A growth in the systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the 7MM is anticipated, as per ...
Systemic lupus erythematosus (SLE) is the most common form of lupus — it’s the type that 7 in 10 people with lupus have. It's what most people mean when they say "lupus." Experts don’t know what ...